Clinical Trials in Montpellier, Montpellier
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 2
Efficacy of Daily IV Administration of Dornase Alfa up to 14 Days Post Subarachnoid Hemorrhage on Functional Independence at 6 Months
SAH (Subarachnoid Hemorrhage)Delayed Cerebral IschemiaRuptured Aneurysm of Intracranial Artery
Fondation Ophtalmologique Adolphe de Rothschild304 enrolled6 locationsNCT06723717
Recruiting
Phase 2
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+7 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 2
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
COVID-19Immunodeficiency
ANRS, Emerging Infectious Diseases256 enrolled18 locationsNCT05587894
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914
Recruiting
Phase 2
Effects of Variation of Sodium Dialysate in ICU
renal replacement therapyAcute Kidney Injury
University Hospital, Montpellier158 enrolled1 locationNCT03329313
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Venous Thromboembolism
Manuel Monreal120,000 enrolled257 locationsNCT02832245
Recruiting
Discovery of Soluble Biomarkers for Pancreatic Cancer Using Innovative All-Patient Inclusive Methodology
Pancreatic Neoplasms
University Hospital, Montpellier200 enrolled1 locationNCT04370574
Recruiting
Pediatric Perioperative Satisfaction Questionnaire
ChildrenSatisfactionPerioperative
University Hospital, Montpellier600 enrolled6 locationsNCT04608968